The Company’s investigational small moleculeglucagon-like peptide-1 ('GLP-1”) receptor agonist ('RA”), BMF-650, demonstrated potent weight loss and good tolerability in obese cynomolgus monkeys A ...

If you’ve heard the buzz about oral probiotics, lozenges or melts that deliver beneficial bacteria to your mouth, you’re not ...

As of September 30, 2025, Corvus had cash, cash equivalents and marketable securities of $65.7 million as compared to $52.0 million as of December 31, 2024. Consistent with last quarter, Corvus ...

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

South Rampart Pharma is working to develop an oral small molecule non-opioid pain treatment which has generated early positive clinical data as a therapy for acute and chronic pain, as well as ...

The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...